Muckle-Wells syndrome effectively treated with canakinumab: is the recommended dosing schedule mandatory?

Simon M Mueller1, Peter Itin, Peter Haeusermann

  • 1Department of Dermatology, University Hospital Basel, Basel, Switzerland. muellersim@uhbs.ch

Dermatology (Basel, Switzerland)
|October 5, 2011
PubMed

Insights

Cryopyrin-associated periodic fever syndrome (CAPS) treatment with canakinumab shows impressive efficacy and tolerability. Individualized dosing may significantly reduce treatment costs for this rare genetic disorder.

Area of Science:

  • Genetics
  • Immunology
  • Pharmacology

Background:

  • Cryopyrin-associated periodic fever syndrome (CAPS) is a rare inherited autoinflammatory disease.
  • Mutations in the NLRP3 gene lead to interleukin-1 overproduction.
  • Muckle-Wells syndrome is a subtype of CAPS.

Observation:

  • Two half-siblings with Muckle-Wells syndrome were treated with canakinumab.
  • Reduced dosing and longer intervals than standard were used.
  • Treatment demonstrated impressive efficacy and tolerability.

Findings:

  • Canakinumab effectively managed Muckle-Wells syndrome in the reported cases.
  • Individualized, 'reflare-guided' administration of canakinumab was explored.
  • This approach could potentially halve annual treatment costs (approx. USD 60,000/patient/year).

Implications:

  • Canakinumab offers a promising therapeutic option for CAPS.
  • Optimized dosing strategies can improve treatment accessibility.
  • Reduced healthcare costs may enhance patient access to novel therapies.

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...